These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31330430)
1. Binding interactions of bacterial lipopolysaccharides to polymyxin B in an amphiphilic carrier 'sodium deoxycholate sulfate'. Madhumanchi S; Suedee R; Nakpheng T; Tinpun K; Temboot P; Srichana T Colloids Surf B Biointerfaces; 2019 Oct; 182():110374. PubMed ID: 31330430 [TBL] [Abstract][Full Text] [Related]
2. Effect of sodium deoxycholate sulfate on outer membrane permeability and neutralization of bacterial lipopolysaccharides by polymyxin B formulations. Madhumanchi S; Suedee R; Kaewpiboon S; Srichana T; Khalil R; Ul-Haq Z Int J Pharm; 2020 May; 581():119265. PubMed ID: 32217155 [TBL] [Abstract][Full Text] [Related]
3. Formulation Optimization and Stability of Polymyxin B Based on Sodium Deoxycholate Sulfate Micelles. Kaewpaiboon S; Srichana T J Pharm Sci; 2022 Aug; 111(8):2249-2257. PubMed ID: 35231496 [TBL] [Abstract][Full Text] [Related]
4. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide. Tsubery H; Ofek I; Cohen S; Fridkin M Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595 [TBL] [Abstract][Full Text] [Related]
5. Binding interactions of bacterial lipopolysaccharide and the cationic amphiphilic peptides polymyxin B and WLBU2. Ryder MP; Wu X; McKelvey GR; McGuire J; Schilke KF Colloids Surf B Biointerfaces; 2014 Aug; 120():81-7. PubMed ID: 24905681 [TBL] [Abstract][Full Text] [Related]
6. Characterizing the effect of polymyxin B antibiotics to lipopolysaccharide on Escherichia coli surface using atomic force microscopy. Oh YJ; Plochberger B; Rechberger M; Hinterdorfer P J Mol Recognit; 2017 Jun; 30(6):. PubMed ID: 28054415 [TBL] [Abstract][Full Text] [Related]
7. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier. Usman F; Khalil R; Ul-Haq Z; Nakpheng T; Srichana T AAPS PharmSciTech; 2018 Jul; 19(5):2077-2086. PubMed ID: 29691753 [TBL] [Abstract][Full Text] [Related]
8. Novel des-fatty acyl-polymyxin B derivatives with Pseudomonas aeruginosa-specific antimicrobial activity. Sato Y; Shindo M; Sakura N; Uchida Y; Kato I Chem Pharm Bull (Tokyo); 2011; 59(5):597-602. PubMed ID: 21532197 [TBL] [Abstract][Full Text] [Related]
9. Mapping residue-specific contacts of polymyxin B with lipopolysaccharide by saturation transfer difference NMR: insights into outer-membrane disruption and endotoxin neutralization. Bhunia A; Bhattacharjya S Biopolymers; 2011; 96(3):273-87. PubMed ID: 20683937 [TBL] [Abstract][Full Text] [Related]
10. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Srimal S; Surolia N; Balasubramanian S; Surolia A Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):679-86. PubMed ID: 8615847 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologically Safe Nanomicelles of Amphotericin B With Lipids: Nuclear Magnetic Resonance and Molecular Docking Approach. Usman F; Ul-Haq Z; Khalil R; Tinpun K; Srichana T J Pharm Sci; 2017 Dec; 106(12):3574-3582. PubMed ID: 28847478 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of binding power of polymyxin B and its simulating peptide to lipopolysaccharides lipoid A]. Zhu ZX; Li WP; Zhang LY; Gong XY Zhonghua Shao Shang Za Zhi; 2004 Aug; 20(4):232-4. PubMed ID: 15447826 [TBL] [Abstract][Full Text] [Related]
13. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures. Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640 [TBL] [Abstract][Full Text] [Related]
14. Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae. Velkov T; Deris ZZ; Huang JX; Azad MA; Butler M; Sivanesan S; Kaminskas LM; Dong YD; Boyd B; Baker MA; Cooper MA; Nation RL; Li J Innate Immun; 2014 May; 20(4):350-63. PubMed ID: 23887184 [TBL] [Abstract][Full Text] [Related]
15. Development of des-fatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity. Katsuma N; Sato Y; Ohki K; Okimura K; Ohnishi K; Sakura N Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):332-6. PubMed ID: 19336926 [TBL] [Abstract][Full Text] [Related]
17. Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. Pristovsek P; Kidric J J Med Chem; 1999 Nov; 42(22):4604-13. PubMed ID: 10579822 [TBL] [Abstract][Full Text] [Related]
18. An inflammation-targeted nanoparticle with bacteria forced release of polymyxin B for pneumonia therapy. Zhang P; Ouyang Q; Zhai T; Sun J; Wu J; Qin F; Zhang N; Yue S; Yang X; Zhang H; Hou Y; Deng L; Wang F; Zhan Q; Yu Q; Qin M; Gan Z Nanoscale; 2022 Oct; 14(41):15291-15304. PubMed ID: 36039653 [TBL] [Abstract][Full Text] [Related]
19. [Study of the binding between bacterial lipopolysaccharides and polymyxin by a bioluminescent method]. Katsev AM; Onuchina IG; Gordienko AI; Beloglazov VA Ukr Biokhim Zh (1999); 2002; 74(6):103-7. PubMed ID: 12924022 [TBL] [Abstract][Full Text] [Related]
20. Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria. Coya JM; Fraile-Ágreda V; de Tapia L; García-Fojeda B; Sáenz A; Bengoechea JA; Kronqvist N; Johansson J; Casals C Front Immunol; 2022; 13():927017. PubMed ID: 36159837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]